Over-the-Counter Hearing Aid Act of 2017

During CES 2023, JLab Will Debut Its New Hearing Health Category, Ultra-Small Earbuds, And Its First Mechanical Keyboard

Retrieved on: 
Thursday, January 5, 2023
Hearing loss, JLab, Kool-Aid, Bluetooth Low Energy, Mouse, Over-the-Counter Hearing Aid Act of 2017, Hearing protection device, Retail, Go First (airline), JAMA Internal Medicine, CES, IOS, Internal medicine, Hearing, Computer Peripherals, Noise, Atmosphere of Earth, Android, OTC, United Work Collective Council, FDA, All Ages, AirPods, CE marking, Collection, Archive, TBD, Personal protective equipment, Dentistry, Mobile phone, Video game console

At CES 2023, JLab is turning up the volume of its usual innovation announcements in a different way.

Key Points: 
  • At CES 2023, JLab is turning up the volume of its usual innovation announcements in a different way.
  • JLab Enters Hearing Health Category With Over-The-Counter Hearing Aids For Adults, And Hearing Protection Products For All Ages
    With the FDA's approval of over-the-counter hearing aids, hearing health is expected to rise in consumer interest and become a high-growth category for both brands and retailers.
  • Hearing loss is the third most common chronic physical condition in the U.S. and carries multiple negative societal and functional characteristics.
  • With the cost of some high-end hearing aids reaching over $10,000, it is not surprising that financial concerns are cited.

Nuheara Announces New US-Based CEO and Engagement of Roth Capital Partners to Explore US Listing

Retrieved on: 
Monday, May 9, 2022
Board, Demant, Hearing, COO, Australian Securities Exchange, GLOBE, US FDA, OEM, Director, Company, Sonova, Electronics, Roth Capital Partners, Lyric Hearing, Hearing loss, OTC, FDA, Industry, Investment banking, Leadership, Over-the-Counter Hearing Aid Act of 2017, HP Inc., DTC, Pharmacy, NUH, CEO, Technology, Growth, Kool-Aid, Awareness, ASX, Acquisition, Pharmaceutical industry, Management, Hearables

Accordingly, the Company has now moved on this interest and engaged Roth Capital Partners to explore US listing alternatives that support dual listings in Australia and the United States of America.

Key Points: 
  • Accordingly, the Company has now moved on this interest and engaged Roth Capital Partners to explore US listing alternatives that support dual listings in Australia and the United States of America.
  • Roth is a relationship-driven investment bank focused on serving emerging growth companies and their investors.
  • As a full-service investment bank, Roth provides capital raising, M&A advisory, analytical research, trading, market-making services and corporate access.
  • In April 2022, Nuheara submitted an FDA 510(k) for its self-fit hearing aid and signed a worldwide trademark licensing agreement with HP Inc.